Condition: Myocardium; Injury · Perioperative/Postoperative Complications · Angiotensin-Converting-Enzyme Inhibitor · Sponsor: Kasr El Aini Hospital
The aim of this study is to estimate the effect of discontinuation of RAS inhibitors on myocardial injury in cancer patients undergoing major abdominal surgeries.
This description comes directly from the study's public registry record.
Khaled Sarhan, MD · +201020067816 · khaled.sarhan@kasralainy.edu.eg
Always discuss trial participation with your own doctor first.
| Cairo university hospitals | Cairo, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06862115